Uncover The Impact on your Patients' Daily Lives
Be ready to recognize recurrent vulvovaginal candidiasis (RVVC)
Nearly 75% of all adult women have had at least one yeast infection in their lifetime.1 Approximately half of these women experience a recurrence, with 6-9% developing recurrent VVC.2-6 RVVC is defined as 3 or more VVC episodes over a 12-month period.1
Chronic yeast infection, RVVC, is defined as
RVVC can have a significant impact on patients' day-to-day lives. In fact, in a recent patient survey, 76% of women found RVVC to be distressing and 96% of women modified their lifestyle to adapt to RVVC.7-9,*
*In a survey of 206 adult women with RVVC.
RVVC may leave women feeling uncomfortable bringing up issues impacting their daily lives. Women impacted by RVVC may have to miss work, on average 39.2 hours per year in the US, stop exercising, change their diet, and face many daily challenges that you can’t help combat if you aren’t told about them.7, 8, 10 Encourage your patients to talk about how RVVC impacts them. Here are some questions to start the conversation.
References: 1. Vulvovaginal candidiasis (VVC). Centers for Disease Control. Accessed October 5, 2021. https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm. 2. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J. 1979;55:645-647. 3. Zeng X, Zhang Y, Zhang T, Xue Y, Xu H, An R. Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi'an: a cross-sectional study. Biomed Res Int. 2018:9703754. 4. Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women's Health. 2019;19:48. 5. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27(4):230-235. 6. Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340-345. 7. Aballéa S, Guelfucci F, Wagner J, et al. Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidiasis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11:169. 8. Data on file. Mycovia Pharmaceuticals, Inc. 9. Nyirjesy P, Peyton C, Weitz MV, et al. Causes of chronic vaginitis: analysis of a prospective database of affected women. Obstet Gynecol. 2006;108(5):1185-1191. 10. Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339-e347.